Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Authors
Posts by Tess Egginton
Tess Egginton
289 POSTS
0 COMMENTS
http://www.pbiforum.net
Featured
GSK completes $1.9bn acquisition of Sierra Oncology
Tess Egginton
-
4th July 2022
0
Featured
Sirana Pharma and Pfizer to investigate novel treatment for a rare bone disease
Tess Egginton
-
4th July 2022
0
APPROVALS
Xenpozyme (olipudase alfa) approved by European Commission as first treatment for ASMD
Tess Egginton
-
4th July 2022
0
APPROVALS
European Commission approves Kite’s CAR T-cell therapy Yescarta to treat relapsed or refractory follicular lymphoma
Tess Egginton
-
29th June 2022
0
Featured
Astellas and Sutro Biopharma collaborate to advance novel immunostimulatory antibody-drug conjugates
Tess Egginton
-
29th June 2022
0
Featured
SureScreen Diagnostics, Guy’s and St Thomas’ and TestCard collaborate to trial monkeypox lateral flow test
Tess Egginton
-
28th June 2022
0
Featured
Ipsen to expand oncology portfolio with $247m acquisition of Epizyme
Tess Egginton
-
28th June 2022
0
Featured
invoX Pharma to acquire F-star Therapeutics for $161 million
Tess Egginton
-
27th June 2022
0
APPROVALS
Cosentyx (secukinumab) receives expanded approvals in EU for use in childhood arthritic conditions
Tess Egginton
-
27th June 2022
0
APPROVALS
MHLW in Japan grants approval for BioMarin’s Voxzogo for children with achondroplasia
Tess Egginton
-
23rd June 2022
0
1
2
3
...
29
Page 1 of 29
